Evidence map›Paper›PMID 41281499›Full record

ArticleWorld journal of gastrointestinal oncology2025

Innovative insights and future research directions in gastric cancer through single-cell RNA sequencing.

Cheng-Fei Zhao, Qu-Wen Li, Shen-Yi Ye, Li-Wen Chen, Zhi-Feng Xu

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cheng-Fei ZhaoSchool of Pharmacy and Medical Technology, Putian University, Putian 351100, Fujian Province, China.
Qu-Wen LiDepartment of Priority Laboratory for Zoonoses Research, Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, Fujian Province, China.
Shen-Yi YeSchool of Pharmacy and Medical Technology, Putian University, Putian 351100, Fujian Province, China.
Li-Wen ChenSchool of Pharmacy and Medical Technology, Putian University, Putian 351100, Fujian Province, China.
Zhi-Feng XuDepartment of Cardiothoracic Surgery, Affiliated Hospital of Putian University, Putian 351100, Fujian Province, China. zhifengxu1972@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) remains one of the leading causes of cancer-related morbidity and mortality globally. Although significant progress has been made in treatment options, the survival rates for GC patients continue to be low. This is primarily attributed to the intricate and insufficiently understood mechanisms of disease progression, as well as the considerable challenges associated with tumor heterogeneity. The recent study by Tang

Indexed as

Artificial intelligenceEarly detectionGastric cancerImmune cellsImmune modulationMulti-omics approachesParacancerous tissuesSingle-cell RNA sequencingSpatial transcriptomicsTumor microenvironment

Identifiers

PMID41281499
PMCPMC12635628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.